Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses. Not affiliated with any government agency. Always verify information with official sources.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Not a government website.

RSS Feed

Home
/
Brands
/
Preferred Pharmaceuticals, Inc.

Preferred Pharmaceuticals, Inc. Recalls

All product recalls associated with Preferred Pharmaceuticals, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 21–25 of 25 recalls

Rosuvastatin Tablets 5mg (Preferred Pharmaceuticals) – Manufacturing Deviation (2023)

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Class II

FDAMar 23, 2023Nationwide• Preferred Pharmaceuticals, Inc.

Montelukast Sodium Tablets 10mg (Preferred Pharmaceuticals) – Manufacturing Deviation (2023)

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Class II

FDAMar 23, 2023Nationwide• Preferred Pharmaceuticals, Inc.

Diclofenac Sodium Solution (Preferred) - Container Defect (2021)

Defective container: Out of specification for container integrity leading to bottles leaking.

Class II

Page 2 of 2Next

FDANov 29, 2021CT, FL, IN +1 more• Preferred Pharmaceuticals, Inc.

Metformin HCl Extended Release (Preferred) – NDMA Impurity (2021)

CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.

Class II

FDAApr 28, 2021FL, IN• Preferred Pharmaceuticals, Inc.

Cephalexin Oral Suspension (Preferred) – impurity issue (2021)

Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin

Class II

FDAApr 12, 2021CA• Preferred Pharmaceuticals, Inc.